{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:37:55Z","timestamp":1790872675501,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.biochi.2004.12.007","type":"journal-article","created":{"date-parts":[[2005,1,13]],"date-time":"2005-01-13T13:51:20Z","timestamp":1105624280000},"page":"65-71","source":"Crossref","is-referenced-by-count":69,"title":["HIV antiretroviral treatment alters adipokine expression and insulin sensitivity of adipose tissue in vitro and in vivo"],"prefix":"10.1016","volume":"87","author":[{"given":"Claire","family":"Lagathu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minji","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha","family":"Maachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Vigouroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Capeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Bastard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biochi.2004.12.007_bib1","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","article-title":"Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study","volume":"353","author":"Carr","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.biochi.2004.12.007_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0166-3542(01)00148-6","article-title":"Metabolic complications associated with antiretroviral therapy","volume":"51","author":"Jain","year":"2001","journal-title":"Antiviral Res."},{"key":"10.1016\/j.biochi.2004.12.007_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/135965350100600301","article-title":"Antiretoviral therapy and the lipodystrophy syndrome, part 2: concepts in aetiopathogenesis","volume":"6","author":"Nolan","year":"2001","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.biochi.2004.12.007_bib4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00126334-200211010-00001","article-title":"Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel","volume":"31","author":"Schambelan","year":"2002","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.biochi.2004.12.007_bib5","doi-asserted-by":"crossref","first-page":"F11","DOI":"10.1097\/00002030-200105040-00001","article-title":"Metabolic effects of indinavir in healthy HIV-seronegative men","volume":"15","author":"Noor","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.biochi.2004.12.007_bib6","doi-asserted-by":"crossref","first-page":"F25","DOI":"10.1097\/00002030-200002180-00001","article-title":"A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome","volume":"14","author":"Carr","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.biochi.2004.12.007_bib7","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/00002030-200007070-00002","article-title":"Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection","volume":"14","author":"Mallal","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.biochi.2004.12.007_bib8","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1007\/s00125-003-1228-z","article-title":"Regulation of adipocytokines and insulin resistance","volume":"46","author":"Fasshauer","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.biochi.2004.12.007_bib9","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.bbrc.2003.10.013","article-title":"Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone","volume":"311","author":"Lagathu","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biochi.2004.12.007_bib10","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1210\/jc.86.6.2817","article-title":"Dexamethasone inhibits tumor necrosis factor-alpha-induced apoptosis and interleukin-1 beta release in human subcutaneous adipocytes and preadipocytes","volume":"86","author":"Zhang","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biochi.2004.12.007_bib11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S1359-6101(03)00052-2","article-title":"Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha","volume":"14","author":"Ruan","year":"2003","journal-title":"Cytokine Growth Factor Rev."},{"issue":"Suppl 3","key":"10.1016\/j.biochi.2004.12.007_bib12","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1038\/sj.ijo.0802502","article-title":"Inflammatory pathways and insulin action","volume":"27","author":"Hotamisligil","year":"2003","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.biochi.2004.12.007_bib13","doi-asserted-by":"crossref","first-page":"E827","DOI":"10.1152\/ajpendo.2001.280.6.E827","article-title":"The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation","volume":"280","author":"Fruhbeck","year":"2001","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.biochi.2004.12.007_bib14","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1210\/jc.86.5.2281","article-title":"Human breast adipocytes express interleukin-6 (IL-6) and its receptor system: increased IL-6 production by beta-adrenergic activation and effects of IL-6 on adipocyte function","volume":"86","author":"Path","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biochi.2004.12.007_bib15","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s001250051218","article-title":"Down regulation of peroxisome proliferator-activated receptorgamma expression by inflammatory cytokines and its reversal by thiazolidinediones","volume":"42","author":"Tanaka","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.biochi.2004.12.007_bib16","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.2337\/diabetes.50.6.1378","article-title":"The HIV protease inhibitor indinavir impairs sterol regulatory element- binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance","volume":"50","author":"Caron","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.biochi.2004.12.007_bib17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0166-3542(00)00102-9","article-title":"HIV protease inhibitors block adipogenesis and increase lipolysis in vitro","volume":"47","author":"Lenhard","year":"2000","journal-title":"Antiviral Res."},{"key":"10.1016\/j.biochi.2004.12.007_bib18","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1097\/00002030-200311210-00005","article-title":"Some HIV protease inhibitors alter lamin A\/C maturation and stability, SREBP-1 nuclear localization and adipocyte differentiation","volume":"17","author":"Caron","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.biochi.2004.12.007_bib19","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00002030-200204120-00005","article-title":"Indinavir inhibits the glucose transporter isoform Glut4 at physiologic concentrations","volume":"16","author":"Murata","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.biochi.2004.12.007_bib20","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1177\/135965350400900607","article-title":"Antiretroviral drugs with adverse effects on adipocyte lipid metabolism and survival alter the expression and secretion of proinflammatory cytokines and adiponectin in vitro","volume":"9","author":"Lagathu","year":"2004","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.biochi.2004.12.007_bib21","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1097\/00002030-200310170-00005","article-title":"Differential effect of HIV protease inhibitors on adipogenesis: intracellular ritonavir is not sufficient to inhibit differentiation","volume":"17","author":"Vernochet","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.biochi.2004.12.007_bib22","doi-asserted-by":"crossref","first-page":"41325","DOI":"10.1074\/jbc.M006474200","article-title":"Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors","volume":"275","author":"Dowell","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biochi.2004.12.007_bib23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/135965350300800509","article-title":"Intracellular disposition and metabolic effects of zidovudine, stavudine and four protease inhibitors in cultured adipocytes","volume":"8","author":"Janneh","year":"2003","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.biochi.2004.12.007_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00002030-200201040-00003","article-title":"Effects of antiretroviral drug combinations on the differentiation of adipocytes","volume":"16","author":"Roche","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.biochi.2004.12.007_bib25","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1097\/00002030-200411050-00004","article-title":"The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro","volume":"18","author":"Caron","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.biochi.2004.12.007_bib26","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1016\/S0021-9258(18)42768-8","article-title":"Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation","volume":"267","author":"Schulze-Osthoff","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biochi.2004.12.007_bib27","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M408687200","article-title":"Human immunodeficiency virus protease inhibitors accumulate into cultured human adipocytes and alter expression of adipocytokines","author":"Vernochet","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biochi.2004.12.007_bib28","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/00002030-200307040-00011","article-title":"Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy","volume":"17","author":"Vigouroux","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.biochi.2004.12.007_bib29","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1210\/jc.2002-021600","article-title":"Regulation of adiponectin in human immunodeficiency virus-infected patients: relationship to body composition and metabolic indices","volume":"88","author":"Tong","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biochi.2004.12.007_bib30","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1210\/jc.2002-020795","article-title":"Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy","volume":"88","author":"Addy","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biochi.2004.12.007_bib31","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0140-6736(02)08094-7","article-title":"Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance","volume":"359","author":"Bastard","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.biochi.2004.12.007_bib32","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1097\/00002030-199911120-00008","article-title":"Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy","volume":"13","author":"Domingo","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.biochi.2004.12.007_bib33","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/00002030-200306130-00007","article-title":"Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy","volume":"17","author":"Nolan","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.biochi.2004.12.007_bib34","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/135965350300800614","article-title":"Contribution of nucleoside-analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level","volume":"8","author":"Nolan","year":"2003","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.biochi.2004.12.007_bib35","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00428-002-0667-0","article-title":"Ultrastructural features of highly active antiretroviral therapy-associated partial lipodystrophy","volume":"441","author":"Lloreta","year":"2002","journal-title":"Virchows Arch."},{"key":"10.1016\/j.biochi.2004.12.007_bib36","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1053\/meta.2002.34704","article-title":"Increased rates of lipolysis among human immunodeficiency virus-infected men receiving highly active antiretroviral therapy","volume":"51","author":"Hadigan","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.biochi.2004.12.007_bib37","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/135965350400900412","article-title":"Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1-infected lipodystrophic patients","volume":"9","author":"Jan","year":"2004","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.biochi.2004.12.007_bib38","doi-asserted-by":"crossref","first-page":"E1072","DOI":"10.1152\/ajpendo.00206.2003","article-title":"Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels","volume":"285","author":"Lihn","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.biochi.2004.12.007_bib39","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1097\/00002030-200308150-00004","article-title":"Expression of adipogenic transcription factors, peroxisome proliferator-activated receptor gamma co-activator 1, IL-6 and CD45 in subcutaneous adipose tissue in lipodystrophy associated with highly active antiretroviral therapy","volume":"17","author":"Kannisto","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.biochi.2004.12.007_bib40","doi-asserted-by":"crossref","first-page":"E261","DOI":"10.1152\/ajpendo.00056.2003","article-title":"Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy","volume":"286","author":"Johnson","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.biochi.2004.12.007_bib41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.0014-2972.2001.00940.x","article-title":"Increased serum interferon alpha in HIV-1 associated lipodystrophy syndrome","volume":"32","author":"Christeff","year":"2002","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.biochi.2004.12.007_bib42","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1097\/00002030-200111090-00004","article-title":"Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways","volume":"15","author":"Van der Valk","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.biochi.2004.12.007_bib43","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1172\/JCI10583","article-title":"Cellular mechanisms of insulin resistance","volume":"106","author":"Shulman","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biochi.2004.12.007_bib44","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1210\/jc.2002-021922","article-title":"Circulating concentration of adiponectin and its expression in subcutaneous adipose tissue in patients with highly active antiretroviral therapy-associated lipodystrophy","volume":"88","author":"Sutinen","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biochi.2004.12.007_bib45","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/00126334-200212150-00009","article-title":"Adiponectin and leptin levels in HIV-infected subjects with insulin resistance and body fat redistribution","volume":"31","author":"Mynarcik","year":"2002","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.biochi.2004.12.007_bib46","doi-asserted-by":"crossref","first-page":"786","DOI":"10.7326\/0003-4819-140-10-200405180-00008","article-title":"Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial","volume":"140","author":"Hadigan","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.biochi.2004.12.007_bib47","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(04)15489-5","article-title":"No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial","volume":"363","author":"Carr","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.biochi.2004.12.007_bib48","doi-asserted-by":"crossref","first-page":"E941","DOI":"10.1152\/ajpendo.00490.2003","article-title":"Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy","volume":"286","author":"Sutinen","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.biochi.2004.12.007_bib49","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/00002030-200303280-00022","article-title":"Glitazones in lipodystrophy syndrome induced by highly active antiretroviral therapy","volume":"17","author":"Calmy","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.biochi.2004.12.007_bib50","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00126334-200210010-00006","article-title":"Improved insulin sensitivity and body fat distribution in HIV-infected patients treated with rosiglitazone: a pilot study","volume":"31","author":"Gelato","year":"2002","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.biochi.2004.12.007_bib51","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/135965350300800303","article-title":"Rosiglitazone in the treatment of HAART-associated lipodystrophy--a randomized double-blind placebo-controlled study","volume":"8","author":"Sutinen","year":"2003","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.biochi.2004.12.007_bib52","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/135965350400900206","article-title":"Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations","volume":"9","author":"Gougeon","year":"2004","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.biochi.2004.12.007_bib53","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1086\/380790","article-title":"Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL study","volume":"38","author":"McComsey","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.biochi.2004.12.007_bib54","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00002030-200404300-00011","article-title":"Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study","volume":"18","author":"Martin","year":"2004","journal-title":"AIDS"}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908404002640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908404002640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T15:03:07Z","timestamp":1682953387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908404002640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0300908404002640"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2004.12.007","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}